These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21719339)
21. Update on pathogen reduction technology for therapeutic plasma: an overview. Solheim BG; Seghatchian J Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528 [TBL] [Abstract][Full Text] [Related]
22. Improving blood safety and patient outcomes with pathogen reduction technology. Goodrich RP; Ettinger A; Radziwon PM; Rock G Transfus Apher Sci; 2011 Dec; 45(3):229-38. PubMed ID: 22078570 [No Abstract] [Full Text] [Related]
23. Alternative strategies in assuring blood safety: An overview. Epstein JS Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174 [TBL] [Abstract][Full Text] [Related]
24. Risks and side effects of therapy with plasma and plasma fractions. MacLennan S; Barbara JA Best Pract Res Clin Haematol; 2006; 19(1):169-89. PubMed ID: 16377549 [TBL] [Abstract][Full Text] [Related]
25. Bacterial contamination in blood components and preventative strategies: an overview. Vasconcelos E; Seghatchian J Transfus Apher Sci; 2004 Oct; 31(2):155-63. PubMed ID: 15501419 [TBL] [Abstract][Full Text] [Related]
26. Issues in transfusion therapy in the patient with malignancy. Friedberg RC Hematol Oncol Clin North Am; 1994 Dec; 8(6):1223-53. PubMed ID: 7860446 [TBL] [Abstract][Full Text] [Related]
33. [Techniques of preparation and indications of labile blood products]. Clément S Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355 [TBL] [Abstract][Full Text] [Related]
34. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products. Goodrich RP; Doane S; Reddy HL Biologicals; 2010 Jan; 38(1):20-30. PubMed ID: 20093041 [TBL] [Abstract][Full Text] [Related]
37. Globalisation and blood safety. Farrugia A Blood Rev; 2009 May; 23(3):123-8. PubMed ID: 19081166 [TBL] [Abstract][Full Text] [Related]
38. Incidence and significance of the bacterial contamination of blood components. Blajchman MA Dev Biol (Basel); 2002; 108():59-67. PubMed ID: 12220143 [TBL] [Abstract][Full Text] [Related]
39. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications. Spinella PC Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261 [TBL] [Abstract][Full Text] [Related]